Teligent Company Profile (NASDAQ:TLGT)

About Teligent (NASDAQ:TLGT)

Teligent logoTeligent, Inc. is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 34 Abbreviated New Drug Application(ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2016.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Pharmaceuticals - NEC
  • Sub-Industry: N/A
  • Symbol: NASDAQ:TLGT
  • CUSIP: N/A
  • Web: www.teligent.com
Capitalization:
  • Market Cap: $452.42 million
  • Outstanding Shares: 53,226,000
Average Prices:
  • 50 Day Moving Avg: $8.88
  • 200 Day Moving Avg: $7.95
  • 52 Week Range: $5.75 - $9.54
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 21.09
  • P/E Growth: 3.330
Sales & Book Value:
  • Annual Revenue: $71.12 million
  • Price / Sales: 6.31
  • Book Value: $1.10 per share
  • Price / Book: 7.70
Profitability:
  • EBIDTA: $9.15 million
  • Net Margins: -14.35%
  • Return on Equity: 5.43%
  • Return on Assets: 1.74%
Debt:
  • Debt-to-Equity Ratio: 1.95%
  • Current Ratio: 5.62%
  • Quick Ratio: 4.83%
Misc:
  • Average Volume: 324,224 shs.
  • Beta: 1.63
  • Short Ratio: 20.2
 
Frequently Asked Questions for Teligent (NASDAQ:TLGT)

What is Teligent's stock symbol?

Teligent trades on the NASDAQ under the ticker symbol "TLGT."

How were Teligent's earnings last quarter?

Teligent, Inc. (NASDAQ:TLGT) issued its earnings results on Tuesday, March, 7th. The company reported $0.01 earnings per share (EPS) for the quarter. The firm had revenue of $17.90 million for the quarter, compared to analysts' expectations of $17.97 million. Teligent had a negative net margin of 14.35% and a positive return on equity of 5.43%. The business's revenue was up 36.6% on a year-over-year basis. During the same quarter last year, the business earned ($0.02) earnings per share. View Teligent's Earnings History.

When will Teligent make its next earnings announcement?

Teligent is scheduled to release their next quarterly earnings announcement on Wednesday, July, 26th 2017. View Earnings Estimates for Teligent.

Where is Teligent's stock going? Where will Teligent's stock price be in 2017?

2 brokerages have issued 12-month price targets for Teligent's shares. Their predictions range from $9.00 to $10.00. On average, they expect Teligent's stock price to reach $9.50 in the next year. View Analyst Ratings for Teligent.

Who are some of Teligent's key competitors?

Who are Teligent's key executives?

Teligent's management team includes the folowing people:

  • Jason Grenfell-Gardner, President, Chief Executive Officer, Director
  • Jenniffer L. Collins, Chief Financial Officer
  • Stephen Richardson, Chief Scientific Officer
  • Carole S. Ben-Maimon M.D., Director
  • John E. Celentano, Director
  • Steven Hubrig Koehler, Director
  • Narendra N. Borkar, Independent Director
  • Bhaskar Michael Chaudhuri Ph.D., Independent Director

Who owns Teligent stock?

Teligent's stock is owned by many different of institutional and retail investors. Top institutional investors include AMI Asset Management Corp (2.66%), Sanders Morris Harris LLC (1.79%), Summit Creek Advisors LLC (1.29%), Atria Investments LLC (0.06%), Aperio Group LLC (0.05%) and Round Table Services LLC (0.03%). Company insiders that own Teligent stock include James C Gale and Jason Grenfell-Gardner. View Institutional Ownership Trends for Teligent.

Who sold Teligent stock? Who is selling Teligent stock?

Teligent's stock was sold by a variety of institutional investors in the last quarter, including Sanders Morris Harris LLC, Summit Creek Advisors LLC, Atria Investments LLC, AMI Asset Management Corp and Round Table Services LLC. View Insider Buying and Selling for Teligent.

Who bought Teligent stock? Who is buying Teligent stock?

Teligent's stock was purchased by a variety of institutional investors in the last quarter, including Aperio Group LLC. Company insiders that have bought Teligent stock in the last two years include James C Gale and Jason Grenfell-Gardner. View Insider Buying and Selling for Teligent.

How do I buy Teligent stock?

Shares of Teligent can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Teligent's stock price today?

One share of Teligent stock can currently be purchased for approximately $8.44.


MarketBeat Community Rating for Teligent (NASDAQ TLGT)
Community Ranking:  2.1 out of 5 ( )
Outperform Votes:  50 (Vote Outperform)
Underperform Votes:  69 (Vote Underperform)
Total Votes:  119
MarketBeat's community ratings are surveys of what our community members think about Teligent and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Teligent (NASDAQ:TLGT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $9.50 (12.63% upside)

Analysts' Ratings History for Teligent (NASDAQ:TLGT)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/17/2017Deutsche Bank AGReiterated RatingHold$8.00 -> $9.00HighView Rating Details
10/28/2016Roth CapitalSet Price TargetBuy$10.00N/AView Rating Details
6/29/2016JMP SecuritiesInitiated CoverageHoldN/AView Rating Details
6/22/2016Raymond James Financial, Inc.Initiated CoverageStrong-Buy$11.00N/AView Rating Details
4/26/2016Oppenheimer Holdings, Inc.Reiterated RatingHoldN/AView Rating Details
(Data available from 7/22/2015 forward)

Earnings

Earnings History for Teligent (NASDAQ:TLGT)
Earnings by Quarter for Teligent (NASDAQ:TLGT)
Earnings History by Quarter for Teligent (NASDAQ TLGT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2017$0.03N/AView Earnings Details
3/7/2017Q4 2016$0.01$17.97 million$17.90 millionViewListenView Earnings Details
10/27/2016Q3$0.00$0.01$16.90 million$16.20 millionViewListenView Earnings Details
7/28/2016Q2($0.02)$0.02$16.03 million$17.14 millionViewListenView Earnings Details
4/28/2016Q116($0.03)$0.02$14.33 million$15.70 millionViewN/AView Earnings Details
3/9/2016Q415($0.02)($0.02)$11.69 million$13.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Teligent (NASDAQ:TLGT)
2017 EPS Consensus Estimate: $0.14
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.03$0.03$0.03
Q2 20171$0.02$0.02$0.02
Q3 20171$0.04$0.04$0.04
Q4 20171$0.05$0.05$0.05
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Teligent (NASDAQ:TLGT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Teligent (NASDAQ:TLGT)
Insider Ownership Percentage: 22.60%
Institutional Ownership Percentage: 63.57%
Insider Trades by Quarter for Teligent (NASDAQ:TLGT)
Institutional Ownership by Quarter for Teligent (NASDAQ:TLGT)
Insider Trades by Quarter for Teligent (NASDAQ:TLGT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/11/2016James C GaleDirectorBuy15,000$4.91$73,650.00View SEC Filing  
3/11/2016Jason Grenfell-GardnerCEOBuy10,500$4.82$50,610.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Teligent (NASDAQ:TLGT)
Latest Headlines for Teligent (NASDAQ:TLGT)
Source:
DateHeadline
streetinsider.com logoTeligent (TLGT) Receives FDA Approval for Erythromycin Topical Gel USP, 2%
www.streetinsider.com - July 22 at 9:39 AM
finance.yahoo.com logoTeligent, Inc. Announces FDA Approval Of Erythromycin Topical Gel USP, 2%
finance.yahoo.com - July 22 at 9:39 AM
finance.yahoo.com logoTeligent Shares Rise on FDA Approval for Erythromycin Topical Gel
finance.yahoo.com - July 22 at 9:39 AM
americanbankingnews.com logoZacks: Analysts Expect Teligent, Inc. (NASDAQ:TLGT) Will Post Quarterly Sales of $20.20 Million
www.americanbankingnews.com - July 22 at 8:24 AM
americanbankingnews.com logo Analysts Expect Teligent, Inc. (TLGT) to Post $0.03 Earnings Per Share
www.americanbankingnews.com - July 20 at 10:15 PM
americanbankingnews.com logoTeligent, Inc. (TLGT) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - July 19 at 8:53 AM
finance.yahoo.com logoTeligent, Inc. breached its 50 day moving average in a Bullish Manner : TLGT-US : July 17, 2017
finance.yahoo.com - July 18 at 9:04 AM
americanbankingnews.com logoDeutsche Bank AG Increases Teligent, Inc. (NASDAQ:TLGT) Price Target to $9.00
www.americanbankingnews.com - July 17 at 5:58 PM
americanbankingnews.com logoCollegium Pharmaceutical (COLL) vs. Teligent (TLGT) Critical Review
www.americanbankingnews.com - July 14 at 10:29 PM
finance.yahoo.com logoETFs with exposure to Teligent, Inc. : July 11, 2017
finance.yahoo.com - July 12 at 8:11 AM
americanbankingnews.com logoTeligent, Inc. (TLGT) Downgraded by Zacks Investment Research to "Sell"
www.americanbankingnews.com - July 6 at 2:00 PM
americanbankingnews.com logoTeligent, Inc. (TLGT) Expected to Announce Quarterly Sales of $20.70 Million
www.americanbankingnews.com - June 28 at 10:12 AM
americanbankingnews.com logo Analysts Expect Teligent, Inc. (TLGT) to Announce $0.03 EPS
www.americanbankingnews.com - June 26 at 8:38 PM
finance.yahoo.com logoETFs with exposure to Teligent, Inc. : June 14, 2017
finance.yahoo.com - June 15 at 2:23 AM
americanbankingnews.com logoAnalyzing Lannett Co (LCI) and Teligent (TLGT)
www.americanbankingnews.com - June 12 at 12:06 AM
americanbankingnews.com logoHead to Head Comparison: Teligent (TLGT) & Theravance Biopharma (TBPH)
www.americanbankingnews.com - June 9 at 7:43 AM
americanbankingnews.com logo Brokerages Expect Teligent Inc (TLGT) Will Post Quarterly Sales of $20.70 Million
www.americanbankingnews.com - June 2 at 1:10 PM
finance.yahoo.com logoETFs with exposure to Teligent, Inc. : May 31, 2017
finance.yahoo.com - May 31 at 10:12 PM
americanbankingnews.com logo Brokerages Expect Teligent Inc (TLGT) Will Post Earnings of $0.03 Per Share
www.americanbankingnews.com - May 31 at 4:22 PM
seekingalpha.com logoTeligent (TLGT) Presents At Bank of America Merrill Lynch 2017 Health Care Conference - Slideshow
seekingalpha.com - May 24 at 8:50 AM
finance.yahoo.com logoETFs with exposure to Teligent, Inc. : May 16, 2017
finance.yahoo.com - May 16 at 8:11 PM
finance.yahoo.com logoTeligent, Inc. To Present At Bank Of America Merrill Lynch Healthcare Conference Taking Place May 16, 2017
finance.yahoo.com - May 16 at 8:46 AM
finance.yahoo.com logoTeligent, Inc. :TLGT-US: Earnings Analysis: Q1, 2017 By the Numbers : May 15, 2017
finance.yahoo.com - May 15 at 7:24 PM
americanbankingnews.com logoZacks: Analysts Expect Teligent Inc (TLGT) to Post $0.03 Earnings Per Share
www.americanbankingnews.com - May 5 at 4:19 PM
americanbankingnews.com logoTeligent (TLGT) Receives News Impact Score of 0.10
www.americanbankingnews.com - May 3 at 8:36 PM
finance.yahoo.com logoETFs with exposure to Teligent, Inc. : May 3, 2017
finance.yahoo.com - May 3 at 6:27 PM
seekingalpha.com logoTeligent's (TLGT) CEO Jason Grenfell-Gardner on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 3 at 10:19 AM
finance.yahoo.com logoTeligent, Inc. To Present At Deutsche Bank 42nd Annual Health Care Conference On May 3, 2017
finance.yahoo.com - May 3 at 10:19 AM
marketbeat.com logoTeligent tops 1Q profit forecasts
marketbeat.com - May 2 at 7:18 PM
finance.yahoo.com logoTeligent, Inc. Announces First Quarter 2017 Results
finance.yahoo.com - May 2 at 6:13 PM
finance.yahoo.com logoInvestor Network: Teligent, Inc. to Host Earnings Call
finance.yahoo.com - May 2 at 8:54 AM
finance.yahoo.com logoThe 3 Best Pharmaceutical Stocks to Buy in 2017
finance.yahoo.com - April 29 at 3:52 PM
americanbankingnews.com logoTeligent (TLGT) Getting Somewhat Negative News Coverage, Study Finds
www.americanbankingnews.com - April 29 at 11:15 AM
americanbankingnews.com logoTeligent (TLGT) Given Daily Coverage Optimism Rating of -0.06
www.americanbankingnews.com - April 25 at 6:31 PM
finance.yahoo.com logoTeligent, Inc. Appoints Martin Wilson To General Counsel
finance.yahoo.com - April 25 at 9:18 AM
americanbankingnews.com logoTeligent (TLGT) Given Coverage Optimism Score of 0.22
www.americanbankingnews.com - April 21 at 10:52 PM
finance.yahoo.com logoTeligent, Inc. To Hold Conference Call For 1st Quarter 2017 Results
finance.yahoo.com - April 21 at 11:48 AM
finance.yahoo.com logoETFs with exposure to Teligent, Inc. : April 20, 2017
finance.yahoo.com - April 20 at 10:17 PM
americanbankingnews.com logoTeligent (TLGT) Receiving Somewhat Critical Media Coverage, Study Finds
www.americanbankingnews.com - April 18 at 10:00 AM
americanbankingnews.com logo$21.03 Million in Sales Expected for Teligent Inc (TLGT) This Quarter
www.americanbankingnews.com - April 16 at 8:28 AM
americanbankingnews.com logoTeligent (TLGT) Earns Daily Coverage Optimism Rating of -0.08
www.americanbankingnews.com - April 15 at 1:48 PM
americanbankingnews.com logo$0.02 Earnings Per Share Expected for Teligent Inc (TLGT) This Quarter
www.americanbankingnews.com - April 14 at 6:20 PM
americanbankingnews.com logoTeligent Inc (TLGT) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - April 13 at 11:10 AM
americanbankingnews.com logoTeligent Inc (TLGT) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - April 11 at 9:06 AM
finance.yahoo.com logoTeligent, Inc. To Present At Oppenheimer 27th Annual Healthcare Conference On March 22, 2017
finance.yahoo.com - March 22 at 8:11 PM
biz.yahoo.com logoTELIGENT, INC. Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statements and Exhibits
biz.yahoo.com - March 18 at 2:08 AM
biz.yahoo.com logoTELIGENT, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 15 at 9:46 PM
finance.yahoo.com logoTeligent, Inc. To Present At 29th Annual ROTH Conference On March 13, 2017
finance.yahoo.com - March 13 at 7:50 PM
nasdaq.com logoTeligent, Inc. (Nasdaq: TLGT) to Ring The Nasdaq Stock Market Closing Bell - Nasdaq
www.nasdaq.com - March 9 at 8:13 PM
streetinsider.com logoTeligent (TLGT) Recieves FDA Approval for Clobetasol Propionate Gel, 0.05%
www.streetinsider.com - March 8 at 10:42 PM

Social

Chart

Teligent (TLGT) Chart for Saturday, July, 22, 2017

This page was last updated on 7/22/2017 by MarketBeat.com Staff